NCT06054061Completed
Evaluation the Efficacy "Think and Cope Positively" Program
Improving Subjective Wellbeing Despite a Severe Psychiatric Condition Through "Think and Cope Positively" Program: A Randomized Control Trial.
Source: ClinicalTrials.gov · Last updated 20 Jul 2026
Brief summary (registry, in English)
The purpose of this study is to determine whether an integrated protocol based on cognitive behavioural therapy, positive psychology and third generation therapies is effective in improve the subjective well-being of people affected by a severe mental illness (SMI). The design of the study is a cluster randomized control trial with two arms. Experimental groups will receive 15 sessions to enhance positive emotions, optimism, adaptive coping, finding a purpose in life and sharing it with people who are important to the user. The control group will remain on a waitlist with their treatment as usual (TAU). After the control period (15 weeks), participants of the experimental groups have the chance to receive the intervention. Both groups will be measure before and after de 15 intervention weeks. Additionally, follow-up measures of the experimental group will be taken after 3 and 6 months.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 449 (actual)
- First submitted
- 5 Sept 2023
- Start date
- 20 Sept 2023
- Primary completion date
- 1 Nov 2023
- Lead sponsor
- Universidad Pontificia Comillas
- Diseases
- Schizophrenia
- NCT number
- NCT06054061
What you commit to
- Study type: Interventional
- Participants enrolled: 449
- From 20 Sept 2023 to the primary completion date, 1 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Altered behavior (relationally) that could alter the good functioning of the group.
- Prior to their participation in the study, the rehabilitation team, in coordination with the research team, will assess whether the patient can benefit from the study.
Other
- Addiction dependence criteria (on the other hand, people with substance abuse criteria will be accepted)
Who the study is looking for
- Users of public psychosocial rehabilitation resources belonging to the Community of Madrid and Castilla la Mancha
- Legal age
- Clinical diagnosis of severe mental disorder: schizophrenia spectrum, bipolar disorder, personality disorders and severe affective disorders.
- Psychopathological stability (or that residual symptoms do not interfere with the course of treatment)
- Minimum level of cognitive comprehension (i.e. no comorbidity with intellectual disability).
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UNINPSI Coordinator of this site? Confirm its status | Madrid | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.